haloperidol has been researched along with vasoactive intestinal peptide in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (47.06) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monzani, E; Panerai, AE; Panza, G; Penati, G; Sacerdote, P | 1 |
| Bloom, SR; Ghatei, MA; Jones, PM; O'Halloran, DJ | 1 |
| Jarvis, WD; Judd, AM; Kovacs, K; Login, IS; MacLeod, RM; Ross, PC; Spangelo, BL | 1 |
| Zafirov, DH | 1 |
| Fukushima, T; Ishibashi, M; Teramoto, A; Yamaji, T | 1 |
| Dominguez, JR; López, FJ; Negro-Vilar, A; Sánchez-Franco, F | 1 |
| Esteve, JP; Laval, J; Ribet, A; Senarens, C; Vaysse, N | 1 |
| Dowling, JE; Watling, KJ | 1 |
| Collu, R; Ducharme, JR; Eljarmak, D; Lafond, J; Marchisio, AM | 1 |
| Blomquist, L; Goiny, M; Posloncec, B; Uvnäs-Moberg, K | 1 |
| Eriksson, E; Nilsson, CL | 1 |
| Carrillo, AJ; Liu, B; Signs, SA; Wolford, J | 1 |
| Blanco, J; Carretero, J; Francos, CM; Rubio, M; Sanchez, F; Vazquez, R | 1 |
| Hirai, M; Kishida, S; Miyabo, S; Mizukami, M; Nakai, T; Ooya, E | 1 |
| Bouchard, P; Dumont, Y; Fournier, A; Quirion, R; St-Pierre, S | 1 |
| Audisio, D; Mauri, MC; Panerai, AE; Panza, G; Rudelli, R; Sacerdote, P; Sicaro, A; Vanni, S | 1 |
| Chariot, J; Presset, O; Rozé, C; Souli, A; Tsocas, A | 1 |
17 other study(ies) available for haloperidol and vasoactive intestinal peptide
| Article | Year |
|---|---|
Beta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and haloperidol-treated schizophrenic patients.
Topics: Adolescent; Adult; beta-Endorphin; Cholecystokinin; Female; Haloperidol; Humans; Male; Monocytes; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Vasoactive Intestinal Peptide | 1992 |
Rat anterior pituitary neuropeptides following chronic prolactin manipulation: a combined radioimmunoassay and mRNA study.
Topics: Animals; Blotting, Northern; Bromocriptine; Female; Galanin; Haloperidol; Hypothalamus; Neuropeptides; Peptides; Pituitary Gland, Anterior; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains; RNA, Messenger; Substance P; Vasoactive Intestinal Peptide | 1991 |
Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine.
Topics: Calcium; Cholera Toxin; Colforsin; Cyclic AMP; Dopamine; Enzyme Activation; Estradiol; Haloperidol; Immunohistochemistry; Marine Toxins; Oxocins; Pertussis Toxin; Pituitary Neoplasms; Prolactin; Protein Kinase C; Tumor Cells, Cultured; Vasoactive Intestinal Peptide; Virulence Factors, Bordetella | 1988 |
Haloperidol, chlorpromazine and lithium chloride antagonize the excitatory action of forskolin and of some gut peptides on guinea-pig myenteric neurones.
Topics: Action Potentials; Animals; Bombesin; Chlorides; Chlorpromazine; Cholecystokinin; Colforsin; Guinea Pigs; Haloperidol; Lithium; Lithium Chloride; Myenteric Plexus; Vasoactive Intestinal Peptide | 1988 |
Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Cells, Cultured; Corticotropin-Releasing Hormone; Cushing Syndrome; Dopamine; Female; Haloperidol; Humans; Lypressin; Nelson Syndrome; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Somatostatin; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide | 1985 |
Role of dopamine and vasoactive intestinal peptide in the control of pulsatile prolactin secretion.
Topics: Animals; Domperidone; Dopamine; Haloperidol; Immunization, Passive; Male; Periodicity; Pimozide; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vasoactive Intestinal Peptide | 1989 |
Dopamine-stimulated cyclic AMP and binding of [3H] dopamine in acini from dog pancreas.
Topics: Amylases; Animals; Binding, Competitive; Cyclic AMP; Dogs; Dopamine; Haloperidol; Kinetics; Pancreas; Receptors, Dopamine; Secretin; Vasoactive Intestinal Peptide | 1982 |
Effects of vasoactive intestinal peptide and other peptides on cyclic AMP accumulation in intact pieces and isolated horizontal cells of the teleost retina.
Topics: Amino Acid Sequence; Animals; Butaclamol; Cyclic AMP; Dopamine; Fishes; Flupenthixol; Glucagon; Haloperidol; Retina; Secretin; Vasoactive Intestinal Peptide | 1983 |
Sodium ions: their role and mechanism of action in the control of prolactin release.
Topics: Animals; Bromocriptine; Cells, Cultured; Cobalt; Dopamine; Female; Haloperidol; Ouabain; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Sodium; Tetrodotoxin; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide; Veratridine | 1984 |
Increased levels of VIP (vasoactive intestinal polypeptide)-like immunoreactivity in peripheral venous blood of dogs following injections of apomorphine and bromocriptine. Do dopaminergic agents induce gastric relaxation and hypotension by a release of en
Topics: Animals; Apomorphine; Bromocriptine; Dogs; Gastrointestinal Hormones; Gastrointestinal Motility; Haloperidol; Hypotension; Muscle Relaxation; Receptors, Dopamine; Vasoactive Intestinal Peptide; Vomiting | 1982 |
Haloperidol increases prolactin release and cyclic AMP formation in vitro: inverse agonism at dopamine D2 receptors?
Topics: 1-Methyl-3-isobutylxanthine; Animals; Cell Line; Cyclic AMP; Dopamine Agents; Haloperidol; Prolactin; Radioimmunoassay; Rats; Receptors, Dopamine D2; Vasoactive Intestinal Peptide | 1993 |
Serotonergic involvement in the regulation of prolactin and vasoactive intestinal peptide mRNA expression in the rat anterior pituitary.
Topics: 5-Hydroxytryptophan; alpha-Methyltyrosine; Animals; Blotting, Northern; Bromocriptine; Gene Expression Regulation; Haloperidol; Ketanserin; Male; Methiothepin; Methoxydimethyltryptamines; Methyltyrosines; Pituitary Gland, Anterior; Prolactin; Quipazine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serotonin; Time Factors; Transcription, Genetic; Vasoactive Intestinal Peptide | 1994 |
In vitro and in vivo evidence for direct dopaminergic inhibition of VIP-immunoreactive pituitary cells.
Topics: Animals; Cells, Cultured; Dopamine; Haloperidol; Image Processing, Computer-Assisted; Immunohistochemistry; Injections, Intraventricular; Male; Pituitary Gland; Rats; Rats, Sprague-Dawley; Vasoactive Intestinal Peptide | 1994 |
[The effects of short and long duration of hypothyroidism on prolactin secretion in rats].
Topics: Animals; beta-Endorphin; Dopamine; Haloperidol; Hypothalamus; Hypothyroidism; Male; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Time Factors; Vasoactive Intestinal Peptide | 1993 |
Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation.
Topics: Animals; Binding, Competitive; Epinephrine; Gastrointestinal Hormones; Haloperidol; Hippocampus; Kinetics; Male; Mice; Mice, Inbred Strains; Neuropeptide Y; Neurotensin; Peptide YY; Peptides; Phenazocine; Receptors, sigma; Vasoactive Intestinal Peptide | 1993 |
Cholecystokinin, beta-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Behavioral Symptoms; beta-Endorphin; Case-Control Studies; Chi-Square Distribution; Cholecystokinin; Female; Haloperidol; Humans; Leukocytes, Mononuclear; Male; Neuropeptides; Regression Analysis; Schizophrenia; Severity of Illness Index; Treatment Outcome; Vasoactive Intestinal Peptide | 1998 |
Neural mechanism of the antisecretory effect of peptide YY in the rat colon in vivo.
Topics: Adrenergic alpha-Antagonists; Animals; Body Water; Colon; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Hexamethonium; Idazoxan; Intestinal Mucosa; Jejunum; Male; Nicotinic Antagonists; Peptide YY; Rats; Rats, Wistar; Sodium Channel Blockers; Tetrodotoxin; Vasoactive Intestinal Peptide | 2000 |